Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Highlights
  • Published:

Alzheimer's disease

Binding screens

Nature Chemistry (2010)Cite this article

Subjects

Small-molecule microarrays facilitate the search for Alzheimer's disease therapeutics by screening compounds that bind to the amyloid-β peptide.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Chen, J., Armstrong, A. H., Koehler, A. N. & Hecht, M. H. Small molecule microarrays enable the discovery of compounds that bind the Alzheimer's Aβ peptide and reduce its cytotoxicity. J. Am. Chem. Soc. 10.1021/ja107552s (2010)

Download references

Authors
  1. Anne Pichon
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pichon, A. Binding screens. Nature Chem (2010). https://doi.org/10.1038/nchem.954

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/nchem.954

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research